Literature DB >> 24944491

Influence of adriamycin on changes in Nanog, Oct-4, Sox2, ARID1 and Wnt5b expression in liver cancer stem cells.

Ding Sun1, Lei Qin1, Yang Xu1, Jian-Xia Liu1, Li-Ping Tian1, Hai-Xin Qian1.   

Abstract

AIM: To determine the influence of Adriamycin (ADM) on the changes in Nanog, Oct4, Sox2, as well as, in ARID1 and Wnt5b expression in liver cancer stem cells.
METHODS: The MHCC97-L and HCCLM3 liver cancer cell lines were selected as the cell models in this study, and were routinely cultured. The 50% lethal dose (LD50) in the cell lines was detected by the MTT assay. Expression changes in liver cancer stem cell related genes (Nanog, Oct-4, Sox2, ARID1, and Wnt5b) were detected by western blot following treatment with ADM (LD50).
RESULTS: The LD50 of ADM in MHCC97-L cells was lower than that in HCCLM3 cells (0.4123 ± 0.0236 μmol/L vs 0.5259 ± 0.0125 μmol/L, P < 0.05). Wnt5b and Nanog were expressed in both MHCC97-L and HCCLM3 cells, while only Sox2 was expressed in HCCLM3 cells. However, neither ARID1A nor Oct4 was detected in these two cell lines. Genes, related to the stem cells, showed different expression in liver cancer cells with different metastatic potential following treatment with ADM (LD50). Wnt5b protein increased gradually within 4 h of ADM (LD50) treatment, while Nanog decreased (P < 0.05). After 12 h, Wnt5b decreased gradually, while Nanog increased steadily (P < 0.05). In addition, only Sox2 was expressed in HCCLM3 cells with high metastatic potential following ADM (LD50) treatment. The expression of Sox2 increased gradually with ADM (LD50) in HCCLM3 cells (P < 0.05).
CONCLUSION: ADM increased the death rate of MHCC97-L and HCCLM3 cells, while the growth suppressive effect of ADM was higher in MHCC97-L cells than in HCCLM3 cells.

Entities:  

Keywords:  Adriamycin; Liver cancer cell; Liver cancer stem cell; Stem cell related gene; Western blot

Mesh:

Substances:

Year:  2014        PMID: 24944491      PMCID: PMC4051940          DOI: 10.3748/wjg.v20.i22.6974

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  Expression of Oct4 in HCC and modulation to wnt/β-catenin and TGF-β signal pathways.

Authors:  FangJun Yuan; Wenbo Zhou; Can Zou; Zhiyun Zhang; Hongsheng Hu; Zongqing Dai; YouShun Zhang
Journal:  Mol Cell Biochem       Date:  2010-06-15       Impact factor: 3.396

2.  Expression of Sox2 in human ovarian epithelial carcinoma.

Authors:  Feng Ye; Yanli Li; Ying Hu; Caiyun Zhou; Yuting Hu; Huaizeng Chen
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-27       Impact factor: 4.553

Review 3.  Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?

Authors:  Fernando Bessone
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

4.  Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates.

Authors:  Brenda K Edwards; Elizabeth Ward; Betsy A Kohler; Christie Eheman; Ann G Zauber; Robert N Anderson; Ahmedin Jemal; Maria J Schymura; Iris Lansdorp-Vogelaar; Laura C Seeff; Marjolein van Ballegooijen; S Luuk Goede; Lynn A G Ries
Journal:  Cancer       Date:  2010-02-01       Impact factor: 6.860

Review 5.  Surgical treatment for liver cancer.

Authors:  Nicole C Tsim; Adam E Frampton; Nagy A Habib; Long R Jiao
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

6.  Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder.

Authors:  Yaoting Gui; Guangwu Guo; Yi Huang; Xueda Hu; Aifa Tang; Shengjie Gao; Renhua Wu; Chao Chen; Xianxin Li; Liang Zhou; Minghui He; Zesong Li; Xiaojuan Sun; Wenlong Jia; Jinnong Chen; Shangming Yang; Fangjian Zhou; Xiaokun Zhao; Shengqing Wan; Rui Ye; Chaozhao Liang; Zhisheng Liu; Peide Huang; Chunxiao Liu; Hui Jiang; Yong Wang; Hancheng Zheng; Liang Sun; Xingwang Liu; Zhimao Jiang; Dafei Feng; Jing Chen; Song Wu; Jing Zou; Zhongfu Zhang; Ruilin Yang; Jun Zhao; Congjie Xu; Weihua Yin; Zhichen Guan; Jiongxian Ye; Hong Zhang; Jingxiang Li; Karsten Kristiansen; Michael L Nickerson; Dan Theodorescu; Yingrui Li; Xiuqing Zhang; Songgang Li; Jian Wang; Huanming Yang; Jun Wang; Zhiming Cai
Journal:  Nat Genet       Date:  2011-08-07       Impact factor: 38.330

7.  Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.

Authors:  Shih-Hwa Chiou; Mong-Lien Wang; Yu-Ting Chou; Chi-Jen Chen; Chun-Fu Hong; Wang-Ju Hsieh; Hsin-Tzu Chang; Ying-Shan Chen; Tzu-Wei Lin; Han-Sui Hsu; Cheng-Wen Wu
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

8.  Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma.

Authors:  Siân Jones; Tian-Li Wang; Ie-Ming Shih; Tsui-Lien Mao; Kentaro Nakayama; Richard Roden; Ruth Glas; Dennis Slamon; Luis A Diaz; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu; Nickolas Papadopoulos
Journal:  Science       Date:  2010-09-08       Impact factor: 47.728

9.  Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma.

Authors:  Nan Ge; Huan-Xin Lin; Xiang-Sheng Xiao; Ling Guo; Hui-Min Xu; Xin Wang; Ting Jin; Xiu-Yu Cai; Yi Liang; Wei-Han Hu; Tiebang Kang
Journal:  J Transl Med       Date:  2010-10-12       Impact factor: 5.531

10.  Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma.

Authors:  Claudia Lengerke; Tanja Fehm; Ralf Kurth; Hans Neubauer; Veit Scheble; Friederike Müller; Friederike Schneider; Karen Petersen; Diethelm Wallwiener; Lothar Kanz; Falko Fend; Sven Perner; Petra M Bareiss; Annette Staebler
Journal:  BMC Cancer       Date:  2011-01-28       Impact factor: 4.430

View more
  6 in total

1.  Carnosol controls the human glioblastoma stemness features through the epithelial-mesenchymal transition modulation and the induction of cancer stem cell apoptosis.

Authors:  Chiara Giacomelli; Simona Daniele; Letizia Natali; Caterina Iofrida; Guido Flamini; Alessandra Braca; M Letizia Trincavelli; Claudia Martini
Journal:  Sci Rep       Date:  2017-11-09       Impact factor: 4.379

2.  Wolf-Hirschhorn Syndrome Candidate 1 (whsc1) Functions as a Tumor Suppressor by Governing Cell Differentiation.

Authors:  Chuan Yu; Xiaomin Yao; Linjie Zhao; Ping Wang; Qian Zhang; Chengjian Zhao; Shaohua Yao; Yuquan Wei
Journal:  Neoplasia       Date:  2017-06-24       Impact factor: 5.715

3.  Rosmarinic Acid Combined with Adriamycin Induces Apoptosis by Triggering Mitochondria-Mediated Signaling Pathway in HepG2 and Bel-7402 Cells.

Authors:  Youxia Huang; Yingjian Cai; Ronggui Huang; Xingzhong Zheng
Journal:  Med Sci Monit       Date:  2018-11-04

Review 4.  Could gastrointestinal tumor-initiating cells originate from cell-cell fusion in vivo?

Authors:  Yang Zhou; Jun-Ting Cheng; Zi-Xian Feng; Ying-Ying Wang; Ying Zhang; Wen-Qi Cai; Zi-Wen Han; Xian-Wang Wang; Ying Xiang; Hui-Yu Yang; Bing-Rong Liu; Xiao-Chun Peng; Shu-Zhong Cui; Hong-Wu Xin
Journal:  World J Gastrointest Oncol       Date:  2021-02-15

5.  Increased cycling cell numbers and stem cell associated proteins as potential biomarkers for high grade human papillomavirus+ve pre-neoplastic cervical disease.

Authors:  Maurice Canham; Chara Charsou; June Stewart; Sharon Moncur; Laura Hoodless; Ramya Bhatia; Duanduan Cong; Heather Cubie; Camille Busby-Earle; Alistair Williams; Victoria McLoughlin; John D M Campbell; Kate Cuschieri; Sarah Howie
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

6.  The SHH/Gli axis regulates CD90-mediated liver cancer stem cell function by activating the IL6/JAK2 pathway.

Authors:  Ketao Zhang; Siyao Che; Chuzhi Pan; Zheng Su; Shangyou Zheng; Shanglin Yang; Huayao Zhang; Wenda Li; Weidong Wang; Jianping Liu
Journal:  J Cell Mol Med       Date:  2018-05-02       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.